Siren Care
Siren Care develops FDA-registered smart socks with embedded temperature sensors that continuously monitor diabetic patients' feet to detect early inflammation. The platform serves patients, healthcare providers, and health plans through Medicare-reimbursed remote patient monitoring and certified provider programs.
- Company typePrivate
- Founded2016
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Siren Care does
Siren Care, Inc. is a San Francisco-based medical device company founded in 2016 that has developed Siren Socks, an FDA-registered Class I medical device consisting of smart socks with embedded temperature sensors that continuously monitor foot temperature to detect early signs of inflammation in diabetic patients at risk of foot ulcers. The platform architecture pairs the proprietary smart textile sensors with the Siren Hub connectivity device, transmitting biometric data (temperature and moisture) to a remote patient monitoring backend where licensed nurses review temperature gradients and alert healthcare providers when plantar hotspots indicate developing injury, typically before visible symptoms appear.
The company operates a three-sided business model addressing patients with diabetes and neuropathy, healthcare providers (primarily podiatrists and primary care physicians enrolled through the Certified Siren Provider program), and health plans/payers (including Medicare, Medicare Advantage, private insurers, and the U.S. Department of Veterans Affairs). Revenue is generated through a combination of hardware sales of replacement socks (distributed automatically when worn out), recurring remote patient monitoring service fees reimbursed by public and private payers, and provider certification and ongoing education services. The broader Siren ecosystem now includes additional RPM devices (glucometer, blood pressure monitor, pulse oximeter, scale, and activity monitor) and the Principal Care Management program for chronic neuropathy management.
Siren has secured strategic backing from Mölnlycke Health Care via an $8 million investment in a $9.5 million round announced in January 2025, alongside earlier venture capital participation from DCM Ventures, Founders Fund, Khosla Ventures, and others. Real-world evidence cited by the company reports an 83% reduction in amputation risk and 68% reduction in foot ulcer risk among Siren Socks users, with $8,027 in net savings per patient per year relative to standard of care.
Siren Care firmographics
Firmographics- Name
- Siren Care
- Legal name
- Siren Care, Inc.
- Website
- https://siren.care
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Siren Care develops FDA-registered smart socks with embedded temperature sensors that continuously monitor diabetic patients' feet to detect early inflammation. The platform serves patients, healthcare providers, and health plans through Medicare-reimbursed remote patient monitoring and certified provider programs.
- Ownership category
- akta.pro rank
Siren Care industry classification
Industry- Product category
- Smart Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Continuous Temperature & Fever Monitoring (Wearable Thermometry) (HLAHACAK)
- akta.pro secondary industries
- Thermometers & Temperature Monitoring (Smart Thermometers) (CRACAQAG), Wearable Medical Alert Devices (Pendants, Watches, Bands) (HSAHAHAI)
Keywords
Where Siren Care is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Siren Care business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Siren Socks Hardware Sales: Sale of smart textile monitoring devices (Siren Socks) to patients, typically prescribed through healthcare providers or distributed via payer partnerships. Socks are replaced automatically when they wear down.
- Remote Patient Monitoring (RPM) Services: Continuous monitoring services where licensed nurses review temperature data and contact patients regularly. Providers receive reimbursement for RPM services through Medicare and private insurance.
- Provider Certification and Network Services: Certified Siren Provider program trains healthcare providers in remote monitoring and virtual care services. Providers gain access to Siren's patient ecosystem and receive ongoing education (CRE - Continued RPM Education).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Medicare and Medicare Advantage Coverage |
| Subscription | Monthly | Private Insurance Coverage |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Siren Care product offering
Product offeringCore offering
Siren Care manufactures and sells Siren Socks, an FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature 24/7 in patients with diabetes and neuropathy. The socks connect via the Siren Hub to a monitoring platform where licensed nurses review temperature data, alert patients and providers to signs of inflammation, and enable remote patient monitoring services reimbursed by Medicare, Medicare Advantage, and private insurance. Siren also operates a Certified Siren Provider program training healthcare providers in remote monitoring and a Principal Care Management program for chronic conditions such as neuropathy.
Product overview
Siren Care offers a platform-plus-devices ecosystem for diabetic foot ulcer prevention. The core product is Siren Socks, an FDA-registered Class I medical device with embedded temperature sensors that continuously monitor foot temperature. All Siren devices connect through the Siren Hub to a unified monitoring platform where licensed nurses review data and alert providers to potential injuries. The ecosystem includes additional remote monitoring devices (Siren Med, Siren Therapy, Siren Glucometer, Siren Blood Pressure Monitor, Siren Pulse Oximeter, Siren Scale, Siren Move) that work alongside the flagship Siren Socks. Services include Remote Patient Monitoring (RPM), the Certified Siren Provider training program, and Principal Care Management for chronic conditions like neuropathy.
Differentiator
Problem solved
Functional benefit
Brands
- Siren Socks: Smart socks with embedded temperature sensors for diabetic foot monitoring
- Siren Sock
Products and services
- Siren Socks FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature to detect early signs of inflammation and help reduce the risk of diabetic foot ulcers and amputations in patients with diabetes and neuropathy.
- Siren Hub Central connectivity device that links all Siren products to the Siren platform for data transmission and remote patient monitoring, enabling continuous foot temperature data flow to licensed nurses and providers.
- Certified Siren Provider Program Training and certification program for healthcare providers in remote patient monitoring and virtual care services using Siren products, including Continued Remote Patient Monitoring Education (CRE), practice differentiation support, and access to Siren's patient ecosystem.
- Remote Patient Monitoring (RPM) Virtual care service enabling healthcare providers to remotely monitor patients using Siren devices, including nurse monitoring, patient outreach, alerts for temperature changes, and provider coordination, reimbursed through Medicare and private insurance.
- Principal Care Management Chronic condition management program initially launched for neuropathy, augmenting the diabetic foot program through Siren Certified Providers to deliver ongoing care management for patients with chronic diabetes-related conditions.
Quantifiable outcome
- 87.5% reduction in diabetic foot ulcers with temperature monitoring
- +5 more outcomes
Companies that use Siren Care
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
Siren Care technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
Siren Care partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- U.S. Department of Veterans Affairs (VA)corePartnership to provide Siren's temperature monitoring technology to active military and veterans living with diabetes and neuropathy. Siren is working to reduce the number of amputations among veteran populations through early detection of foot issues.
- Lovell Federal Health Care CenterminorPartnership with Lovell Federal Health Care Center to extend critical preventative diabetic foot ulcer technology to active military and veteran populations.
Scale indicators10 records
Recent moves5 records
Expansion highlights6 records
Siren Care competitors and assessment
Company assessmentDirect peers
- Podimetrics: Podimetrics makes a smart temperature monitoring mat that diabetic patients step on for 20 seconds daily to detect early signs of foot ulcers. It is the most direct competitor to Siren Socks in the temperature-based diabetic foot ulcer prevention category, targeting the same patient population, providers, and payers with a similar clinical value proposition.
- Orpyx Medical Technologies: Orpyx produces sensor-equipped insoles (Orpyx SI) that continuously monitor foot temperature, pressure, and other signals to prevent diabetic foot ulcers. It is a direct competitor to Siren in the diabetic foot ulcer prevention space, addressing the same patient population with continuous monitoring hardware reimbursed through similar RPM codes.
Emerging players
- Bonbouton: Bonbouton developed smart insoles with embedded sensors to monitor foot temperature and pressure for early detection of diabetic foot ulcers. It is an emerging direct competitor to Siren in continuous temperature-based foot monitoring, though with a smaller commercial footprint and different form factor (insole vs sock).
- Sensoria Health: Sensoria Health develops smart textile sensors embedded in socks and garments for health and activity monitoring, with applications in diabetic foot care, rehabilitation, and sports. It shares Siren's underlying smart-textile technology stack and form factor, but currently focuses more on activity tracking and rehabilitation rather than continuous temperature monitoring for diabetic foot ulcer prevention.
Broad incumbents
- Vivify Health: Vivify Health is an established remote patient monitoring platform used by health systems and payers for chronic disease management, including diabetes. It is a broader incumbent in the RPM space that Siren competes with for health plan contracts and provider attention, though Vivify's offering is software-first and disease-agnostic versus Siren's vertically integrated sock-and-platform approach.
- Health Recovery Solutions (HRS): HRS provides a tablet-based remote patient monitoring platform used by hospitals and home health agencies to monitor patients with chronic conditions including diabetes. It competes with Siren for RPM reimbursement dollars and health system relationships, but operates as a hardware-agnostic software platform rather than a vertically integrated device company.
- Dexcom: Dexcom is the leading continuous glucose monitor manufacturer and a major player in diabetes-related remote monitoring. While its product is CGM-focused rather than temperature-based, it serves the same diabetic patient population and has established relationships with endocrinologists, payers, and Medicare that Siren needs to access for population-scale deployment.
- Abbott Diabetes Care: Abbott's FreeStyle Libre continuous glucose monitor franchise is a major diabetes monitoring incumbent with deep payer relationships and global distribution. Like Dexcom, Abbott is not a direct temperature-monitoring competitor but represents a scale player in the diabetes monitoring ecosystem where Siren operates and into which it could expand via the Siren Glucometer product.
- Resideo Life Care Solutions: Resideo's Life Care Solutions business provides remote patient monitoring services to health plans and home health agencies, including chronic condition monitoring for diabetes populations. It is a broader RPM incumbent that competes with Siren for payer contracts, though its offering is more focused on elderly fall risk and general vitals monitoring than diabetic foot ulcer prevention specifically.
Others
- Mölnlycke Health Care: Mölnlycke Health Care is a global wound care and surgical solutions leader that made an $8M strategic investment in Siren Care in January 2025. While not a competitor, Mölnlycke is the most strategically relevant partner for Siren — its wound care portfolio targets the same end prescribers (podiatrists, wound clinics) that Siren serves, making it both a channel partner and a potential acquirer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Siren Care social profiles
Digital presenceSiren Care compliance and trust
Trust signalCompliance3 records
Siren Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Siren Care leadership team
Management profileNumber of profiles
Profiles7 records
Siren Care funding detail
Funding detailFunding overview
Funding rounds15 records
Investors18 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Siren Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Siren Care
What does Siren Care do?
Siren Care manufactures and sells Siren Socks, an FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature 24/7 in patients with diabetes and neuropathy. The socks connect via the Siren Hub to a monitoring platform where licensed nurses review temperature data, alert patients and providers to signs of inflammation, and enable remote patient monitoring services reimbursed by Medicare, Medicare Advantage, and private insurance. Siren also operates a Certified Siren Provider program training healthcare providers in remote monitoring and a Principal Care Management program for chronic conditions such as neuropathy.
Is Siren Care a public or private company?
Siren Care is a private company. It is classified as venture growth investor backed and is currently operating.
When was Siren Care founded?
Siren Care was founded in 2016. It employs 11 to 50 people.
Where is Siren Care based?
Siren Care is headquartered in San Francisco, United States, in the North America region.
How does Siren Care make money?
Three revenue lines are on record. Siren Socks Hardware Sales are the primary driver. The others are remote Patient Monitoring (RPM) Services and provider Certification and Network Services.
Who are Siren Care's main competitors?
Direct peers on record are Podimetrics and Orpyx Medical Technologies. Emerging players are Bonbouton and Sensoria Health. Broad incumbents are Vivify Health, Health Recovery Solutions (HRS), Dexcom, Abbott Diabetes Care and Resideo Life Care Solutions. Mölnlycke Health Care is listed as an others.
Does Siren Care have an API?
No public API is recorded for Siren Care.
What industry is Siren Care in?
Siren Care's product category is Smart Medical Devices. Its primary akta.pro industry code is HLAHACAK, Continuous Temperature & Fever Monitoring (Wearable Thermometry), with a secondary code of CRACAQAG, Thermometers & Temperature Monitoring (Smart Thermometers). Its NAICS code is 334510 and its SIC code is 3845.